Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Common Antimicrobial May Raise Risk of Colon Disease
Disease Discoveries

Common Antimicrobial May Raise Risk of Colon Disease

By Anna WilliamsJun 15, 2018
Share
Facebook Twitter Email
Guang-Yu Yang, MD, PhD, Pathology
Guang-Yu Yang, MD, PhD, chief of Anatomic Pathology in the Department of Pathology, was a co-author of the study published in Science Translational Medicine.

Triclosan triggers gut inflammation in animal model

Triclosan — an antimicrobial widely used in toothpastes, cosmetics and other household products — may raise the risk of gut inflammation and colorectal cancer, according to the results of a preliminary animal study published in Science Translational Medicine.

“Our findings highlight the need to reassess the effects of triclosan on human health, and potentially update policies regulating its use,” said co-author Guang-Yu Yang, MD, PhD, vice chair of Pathology and chief of Anatomic Pathology in the Department.

Triclosan is one of the most commonly used antimicrobials in the U.S. The compound is currently found in more than 2,000 consumer products — from cosmetics and daily hygiene products to even kitchenware and some toys — and its exposure throughout the population is significant; previous research has found that triclosan is detected in about 75 percent of urine samples in the U.S.

But while past studies have suggested possible toxic effects of triclosan at high concentrations, it has remained unclear what health impact the chemical might have at normal exposure levels.

In the current study, a team of investigators studied the effects of triclosan exposure on gut inflammation and associated colon cancer in mouse models. The mice were administrated the chemical for three weeks, at relatively low concentrations comparable to those found in human blood.

The scientists discovered that triclosan increased inflammation of the colon, exacerbated colitis symptoms and promoted colitis-associated colon cancer in mice. The findings also revealed a possible mechanism for such effects: Triclosan exposure changed the composition of the mice’s gut microbiome, which may be behind the results observed by the scientists.

“Exposure to triclosan alters gut microbiota in mice, and its proinflammatory effect is attenuated in germ-free mice, suggesting that gut microbiota is required for the biological effects of triclosan,” explained Yang, also the Joseph C. Calandra Research Professor of Pathology and Toxicology.

Although the findings in the animal model are preliminary — and do not necessarily translate to humans — the authors note that the study lends support to the need for further research into the safety of triclosan, especially given its pervasive use.

Yang is also a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

The study, led by investigators at the University of Massachusetts Amherst, was supported by a new faculty start-up from the University of Massachusetts Amherst, U.S. Department of Agriculture’s National Institute of Food and Agriculture (USDA NIFA) grant 2016-67017-24423 and NIH/National Cancer Institute grant R03CA218520, USDA NIFA grant 2016-67017-24416, USDA NIFA grants 2014-67021-21598 and 2016-67021-25147 and National Natural Science Foundation of China grant 21676212.

Cancer Pathology Research
Share. Facebook Twitter Email

Related Posts

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Comments are closed.

Latest News

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022

Expanded Role for Calcium Channels in T-Cells

Jun 17, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20220607_Feinberg Campus_0070
20220607_Feinberg Campus_0066
20220607_Feinberg Campus_0054
Northwestern University 2022. Photo by Jim Prisching
20220607_Feinberg Campus_0077
20220607_Feinberg Campus_0063
20220607_Feinberg Campus_0111
20220607_Feinberg Campus_0083
20220607_Feinberg Campus_0018
20220607_Feinberg Campus_0023
20220607_Feinberg Campus_0072 (2)
20220607_Feinberg Campus_0120

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.